Physician profile
Robert Flowers
NPI 1407143951
$1,755.21
in general payments reported to CMS, 2019-2025
16 companies · $763 in 2025
The $763 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.94 · 2021: $109 · 2022: $277 · 2023: $214 · 2024: $369 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,345.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $309.57 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $297.87 | 2022-2025 | |
| Glaxosmithkline, LLC. | $265.09 | 2021-2025 | Shingrix, Arexvy |
| Abbvie INC. | $142.33 | 2022-2025 | |
| Lilly USA, LLC | $137.99 | 2021-2024 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $126.49 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $124.45 | 2021-2025 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $85.39 | 2025 | |
| Depuy Synthes Sales INC. | $80.65 | 2019-2025 | Orthovisc, Monovisc |
| Abbott Laboratories | $36.00 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Braintree Laboratories, INC. | $30.68 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.92 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $27.18 | 2022 | |
| Ossur Americas, INC. | $23.36 | 2024 | Miami J |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.05 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Althera Pharmaceuticals LLC | $18.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Flowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.